跳至主要内容
临床试验/NCT00725179
NCT00725179已完成不适用

Treatment of Acetaminophen Toxicity With Intravenous vs Oral N-acetylcysteine: A Retrospective Review

Akron Children's Hospital1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2008年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
130
试验地点
1
主要终点
Duration of oral vs IV NAC treatment in hours

研究概览

简要总结

Retrospective chart review of patients who received N-acetylcysteine for APAP toxicity to assess length of oral vs IV treatment and overall healthcare costs.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Admitted to CHMCA between June 1, 2004 to May 31, 2008 with a qualifying ICD-9 diagnosis code for the following APAP overdose situations; poisoning, accidental, suicide attempt, therapeutic use, assault, and undetermined (965.4, E850.4, E950.0, E935.4, E962.0, E980.0)
  • Serum APAP concentrations ≥ 150 g/mL at 4 hours or a serum concentration above the possible hepatotoxic line on the Rumack-Matthew's nomogram if obtained > 4 hours post ingestion
  • Between the ages of 0-21 years

排除标准

  • Serum APAP concentrations are not actually documented
  • Patient did not receive oral or IV NAC treatment
  • Patient has a preexisting liver disease such as cirrhosis or hepatitis C
  • Patient > 21 years of age

结局指标

主要结局

Duration of oral vs IV NAC treatment in hours

时间窗: From admission to discharge

次要结局

  • Overall healthcare costs associated with IV vs Oral NAC treatment(From admission to discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Martha Blackford

PharmD

Akron Children's Hospital

研究点 (1)

Loading locations...

相似试验